SCPH - SCファ―マシュ―ティカルズ (scPharmaceuticals Inc.)

SCPHのニュース

   scPharmaceuticals names Rachael Nokes as CFO  2022/12/19 13:10:13 Seeking Alpha
scPharmaceuticals (SCPH) said Monday it appointed Rachael Nokes, SVP of finance, as CFO.Nokes joined the company in 2014 from BG Medicine, a publicly traded medical device company,…
   MCRB, TASK and LILAK are among after hours mover  2022/12/07 22:56:49 Seeking Alpha
Gainers: scPharmaceuticals (SCPH) +9%. HashiCorp (HCP) +9%
   Analysts Set scPharmaceuticals Inc. Target Price at $16.40  2022/12/04 06:55:12 Business Mag
Shares of scPharmaceuticals Inc. have received a consensus rating of “Buy” from the six analysts that are covering the stock, MarketBeat reports. Five investment analysts have…
   Boom Or Bust: What Are scPharmaceuticals Inc.’s (NASDAQ:SCPH) Future Prospects?  2022/12/03 15:30:00 Marketing Sentinel
scPharmaceuticals Inc. (NASDAQ:SCPH)’s traded shares stood at 0.35 million during the last session, with the company’s beta value hitting 0.19. At the close of trading, the stock’s price was $7.05, to imply a decrease of -0.98% or -$0.07 in intraday trading. The SCPH share’s 52-week high remains $7.96, putting it -12.91% down since that peak … Boom Or Bust: What Are scPharmaceuticals Inc.’s (NASDAQ:SCPH) Future Prospects? Read More »
   How Are Things Looking For scPharmaceuticals Inc. (NASDAQ: SCPH) For The Short Term?  2022/11/23 12:30:00 Stocks Register
scPharmaceuticals Inc. (NASDAQ:SCPH) traded at $6.97 at close of the session on Tuesday, 11/22/22, made an upward move of 14.45% on its previous day’s price. Looking at the stock we see that its previous close was $6.09 and the beta (5Y monthly) reads 0.23 with the day’s price range being $5.80 – $7.33. In terms … How Are Things Looking For scPharmaceuticals Inc. (NASDAQ: SCPH) For The Short Term? Read More »
   scPharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment Conference  2022/09/01 12:00:00 GlobeNewswire
BURLINGTON, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, announced today that John Tucker, president & chief executive officer, is scheduled to present virtually at the H.C. Wainwright 24 th Annual Global Investment Conference, which is being held in a hybrid format, in-person and virtually, from September 12-14 in New York.
   scPharmaceuticals GAAP EPS of -$0.35 misses by $0.05  2022/08/09 12:35:52 Seeking Alpha
scPharmaceuticals press release (SCPH): Q2 GAAP EPS of -$0.35 misses by $0.05.“The key highlight of the second quarter of 2022 was clearly the FDA’s acceptance of our FUROSCIX NDA…
   scPharmaceuticals Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update  2022/08/09 11:00:00 GlobeNewswire
Announced FDA acceptance of FUROSCIX ® New Drug Application and Prescription Drug User-Fee Act target action date of October 8, 2022
   scPharmaceuticals Inc. to Host FUROSCIX (furosemide) 80mg/10mL for Subcutaneous Administration Commercial Day: An Investigational Treatment for Heart Failure Patients  2022/06/30 12:00:00 Wallstreet:Online
Virtual event scheduled for Wednesday, July 13 at 10:00 AM EDT BURLINGTON, Mass., June 30, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that the Company is hosting
   scPharmaceuticals to Present at the H.C. Wainwright Global Investment Conference  2022/05/17 12:00:00 GlobeNewswire
BURLINGTON, Mass., May 17, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, president & chief executive officer, is scheduled to present at the H.C. Wainwright Global Investment Conference on Tuesday, May 24 at 3:00pm EDT, at the Fontainebleau Miami Beach Hotel in Miami, FL.
   scPharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment Conference  2022/09/01 12:00:00 GlobeNewswire
BURLINGTON, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, announced today that John Tucker, president & chief executive officer, is scheduled to present virtually at the H.C. Wainwright 24 th Annual Global Investment Conference, which is being held in a hybrid format, in-person and virtually, from September 12-14 in New York.
   scPharmaceuticals GAAP EPS of -$0.35 misses by $0.05  2022/08/09 12:35:52 Seeking Alpha
scPharmaceuticals press release (SCPH): Q2 GAAP EPS of -$0.35 misses by $0.05.“The key highlight of the second quarter of 2022 was clearly the FDA’s acceptance of our FUROSCIX NDA…
   scPharmaceuticals Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update  2022/08/09 11:00:00 GlobeNewswire
Announced FDA acceptance of FUROSCIX ® New Drug Application and Prescription Drug User-Fee Act target action date of October 8, 2022
   scPharmaceuticals Inc. to Host FUROSCIX (furosemide) 80mg/10mL for Subcutaneous Administration Commercial Day: An Investigational Treatment for Heart Failure Patients  2022/06/30 12:00:00 Wallstreet:Online
Virtual event scheduled for Wednesday, July 13 at 10:00 AM EDT BURLINGTON, Mass., June 30, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that the Company is hosting
   scPharmaceuticals to Present at the H.C. Wainwright Global Investment Conference  2022/05/17 12:00:00 GlobeNewswire
BURLINGTON, Mass., May 17, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, president & chief executive officer, is scheduled to present at the H.C. Wainwright Global Investment Conference on Tuesday, May 24 at 3:00pm EDT, at the Fontainebleau Miami Beach Hotel in Miami, FL.

calendar